MiMedx Group (MDXG) vs SpyGlass Pharma (SGP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
SpyGlass Pharma is the larger company by market cap ($823.5 million vs $674.2 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MDXG | SGP |
|---|---|---|
| Share price | $4.62 | $24.62 |
| Market cap | $674.22M | $823.49M |
| 1-day change | +0.22% | +3.01% |
| YTD return | -31.91% | — |
| 1-year return | -36.50% | — |
| 5-year return | -31.80% | — |
| P/E ratio (TTM) | 115.50 | — |
| Forward P/E | 23.10 | — |
| EPS (TTM) | $0.04 | $-2.51 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.97 | $32.44 |
| 52-week low | $3.03 | $17.06 |
| Distance from 52-week high | -42.03% | -24.11% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +60.17% | +78.72% |
| Average volume | 1.23M | 111.13K |
| Shares outstanding | 145.93M | 33.45M |
| Employees | 808 | 76 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About MiMedx Group
MDXG stock →MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare.
Health Care · Medical/Dental Instruments · 808 employees
About SpyGlass Pharma
SGP stock →SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions.
Health Care · Medical/Dental Instruments · 76 employees
MDXG vs SGP FAQ
Which is bigger, MiMedx Group or SpyGlass Pharma?
SpyGlass Pharma (SGP) is larger, with a market capitalization of $823.49M compared with $674.22M for MiMedx Group (MDXG).
Are MiMedx Group and SpyGlass Pharma in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.